Growth Metrics

Vycor Medical (VYCO) Notes Payables (2010 - 2026)

Vycor Medical (VYCO) reported Notes Payables of $312920.0 for Q1 2026, up 1.65% year-over-year from $307832.0 in Q1 2025, and down 4.3% on a QoQ basis from $326978.0 in Q4 2025.

Vycor Medical (VYCO) has 17 years of Notes Payables data on file, last reported at $312920.0 in Q1 2026.

  • Quarterly Notes Payables rose 1.65% year-over-year to $312920.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $312920.0 (up 1.65% YoY) and the FY2025 annual result came in at $326978.0, up 0.86% from the prior year.
  • Notes Payables eased to $312920.0 in Q1 2026 per VYCO's latest filing, from $326978.0 in the prior quarter.
  • Across five years, Notes Payables topped out at $340939.0 in Q3 2025 and bottomed at $302121.0 in Q2 2022.
  • The 5-year median for Notes Payables is $313140.0 (2024), against an average of $319125.0.
  • Peak annual rise in Notes Payables reached 5.25% in 2022, while the deepest fall reached 27.58% in 2022.
  • Tracing VYCO's Notes Payables over 5 years: stood at $324711.0 in 2022, then grew by 1.1% to $328267.0 in 2023, then decreased by 1.24% to $324185.0 in 2024, then grew by 0.86% to $326978.0 in 2025, then slipped by 4.3% to $312920.0 in 2026.
  • Per Business Quant, the three latest VYCO Notes Payables figures stand at $312920.0 (Q1 2026), $326978.0 (Q4 2025), and $340939.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Vycor Medical - - 375,153.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 312,920.00
Dec 31, 2025 326,978.00
Sep 30, 2025 340,939.00
Jun 30, 2025 303,074.00
Mar 31, 2025 307,832.00
Dec 31, 2024 324,185.00
Sep 30, 2024 337,179.00
Jun 30, 2024 303,409.00
Mar 31, 2024 313,140.00
Dec 31, 2023 328,267.00
Sep 30, 2023 338,786.00
Jun 30, 2023 303,410.00
Mar 31, 2023 311,396.00
Dec 31, 2022 324,711.00
Sep 30, 2022 337,721.00
Jun 30, 2022 400,873.00
Mar 31, 2022 309,057.00
Dec 31, 2021 320,873.00
Sep 30, 2021 320,873.00
Jun 30, 2021 320,873.00
Mar 31, 2021 320,873.00
Dec 31, 2020 310,873.00
Sep 30, 2020 310,873.00
Jun 30, 2020 310,873.00
Mar 31, 2020 290,873.00
Dec 31, 2019 230,873.00
Sep 30, 2019 351,058.00
Jun 30, 2019 325,568.00
Mar 31, 2019 347,643.00
Dec 31, 2018 193,000.00
Sep 30, 2018 193,000.00
Jun 30, 2018 163,000.00
Mar 31, 2018 30,000.00
Dec 31, 2017 318,393.00
Sep 30, 2017 336,145.00
Jun 30, 2017 316,893.00
Mar 31, 2017 331,243.00
Dec 31, 2016 316,856.00
Sep 30, 2016 334,359.00
Jun 30, 2016 312,153.00
Mar 31, 2016 325,813.00
Dec 31, 2015 346,099.03
Mar 31, 2015 330,259.00
Dec 31, 2014 402,177.67
Sep 30, 2014 352,997.00
Jun 30, 2014 311,445.00
Mar 31, 2014 328,338.00
Dec 31, 2013 2.37 Mn
Sep 30, 2013 496,668.00
Jun 30, 2013 2.61 Mn
Mar 31, 2013 300,000.00
Dec 31, 2012 1.73 Mn
Sep 30, 2012 2.07 Mn
Jun 30, 2012 1.63 Mn
Mar 31, 2012 1.64 Mn
Dec 31, 2011 1.64 Mn
Sep 30, 2011 1.63 Mn
Jun 30, 2011 504,825.00
Dec 31, 2010 1.42 Mn